Table 2.
Summary of the drug encapsulated, kind of application, production technique and characteristics of transfersomes obtained in the different works described
| TRANSFERSOMES | ||||||
|---|---|---|---|---|---|---|
| Encapsulated drug | Application | Production technique | Type of lipid/surfactant |
Size
[nm] |
ζ-potential
[mV] |
Ref. |
| Tetanus-toxoid | Topical immunization | Thin film hydration | PC, sodium deoxycholate | 172–195 | - | [83] |
| Plasmid DNA | Hepatitis B vaccines | Reverse phase evaporation | DOTMA, sodium deoxycholate | 85–91 | From − 1 to + 8 | [87] |
| Ovalbumin | Evaluation of antigen productions via microneedles | Thin film hydration | PC, sodium cholate, steatrylamine | 122–199 | + 40 | [89] |